PriTest is medical technology company developing, validating, and delivering faster, more accurate, and more cost-effective tests, and the associated laboratory equipment, to detect biomarkers of infection and chronic disease to large markets worldwide, including the large underserved-market of screening for latent Tuberculosis (TB) infection.